Hostname: page-component-848d4c4894-hfldf Total loading time: 0 Render date: 2024-05-16T02:00:02.265Z Has data issue: false hasContentIssue false
  • English
  • Français

Olanzapine metabolism by CYP1A2/CYP2D6 and hyperglycaemia

Published online by Cambridge University Press:  24 June 2014

Kazuhiko Iwahashi
Kazuhiko Iwahashi*
Affiliation:
Health Administration Center, Azubu University, Sagamihara-City, Japan
*
Kazuhiko Iwahashi, MD, PhD, Health Administration Center, Azubu University, Sagamihara-City, 229-8501, Japan. E-mail: iwahashi@azabu-u.ac.jp
Get access Rights & Permissions [Opens in a new window]

Abstract

The relationship between olanzapine metabolism by CYP1A2/CYP2D6 and hyperglycaemia was investigated. The higher blood olanzapine concentration may be effected by the abnormal metabolism, but not always caused by hyperglycaemia.

Keywords

olanzapinehyperglycaemiaCYP1A2CYP2D6
Type
Case Report
Information
Acta Neuropsychiatrica , Volume 16 , Issue 4 , August 2004 , pp. 229 - 230
Copyright
Copyright © 2004 Blackwell Munksgaard

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Meatherall, R, Younes, J. Fatality from olanzapine induced hyperglycemia. J Forensic Sci 2002;47: 893–896.CrossRefGoogle ScholarPubMed
Kozian, R. Olanzapine-induced diabetes mellitus. Psychiatr Prax 2002;29: 318–320.DOI: 10.1055/s-2002-34039CrossRefGoogle ScholarPubMed
Caccia, S. New antipsychotic agents for schizophrenia: pharmacokinetics and metabolism update. Curr Opin Invest Drugs 2002;3: 1073–1080. Google ScholarPubMed
Nakajima, M, Yokoi, T, Mizutani, M, Kinoshita, M, Funayama, M, Kamataki, T. Genetic polymorphism in the 5′-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans. J Biochem (Tokyo) 1999;125: 803–808.CrossRefGoogle ScholarPubMed
Chida, M, Yokoi, T, Fukui, T, Kinoshita, M, Yokota, J, Kamataki, T. Detection of three genetic polymorphisms in the 5′-flanking region and intron 1 of human CYP1A2 in the Japanese population. Jpn J Cancer Res 1999;90: 899–902.CrossRefGoogle ScholarPubMed
Yokota, H, Tamura, S, Furuya, Het al. Evidence for a new variant CYP2D6 allele CYP2D6J in a Japanese population associated with lower in vivo rates of sparteine metabolism. Pharmacogenetics 1993;3: 256–263.CrossRefGoogle Scholar
Gaedigk, A, Blum, M, Gaedigk, R, Eichelbaum, M, Meyer, UA. Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphism. Am J Hum Genet 1991;485: 943–950. Google Scholar